Garred, P., Eugen-Olsen, J., Iversen, A., Benfield, T., Svejgaard, A., Hofmann, B., Koppelhus, U., Pedersen, C., Sørensen, A., Katzenstein, T., Gerstoft, J., Skinhøj, P., Nielsen, J., & Dickmeiss, E. (2016). Dual effect of CCR5 Δ32 gene deletion in HIV-1-infected patients [2]. Lancet, 349(9069), 1884–1884.

Garred, P., et al. “Dual Effect of CCR5 Δ32 Gene Deletion in HIV-1-Infected Patients [2].” Lancet, vol. 349, no. 9069, 2016, pp. 1884–84.

Garred, P, J Eugen-Olsen, A Iversen, T Benfield, A Svejgaard, B Hofmann, U Koppelhus, et al. 2016. “Dual Effect of CCR5 Δ32 Gene Deletion in HIV-1-Infected Patients [2].” Lancet 349 (9069): 1884–84.